Montelukast Added to Standard Therapy for Acute Asthma in Children Age 6-14 Years
Status:
Terminated
Trial end date:
2005-02-01
Target enrollment:
Participant gender:
Summary
Oral montelukast is helpful in chronic asthma. The purpose of this pediatric study was to
investigate whether the addition of oral montelukast to standard therapy for acute asthma
exacerbations results in further improvement in breathing function over three hours.
Phase:
N/A
Details
Lead Sponsor:
Washington University School of Medicine
Collaborators:
Ambulatory Pediatric Association American Academy of Pediatrics